At the end of Q4 2024, 25 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings, up 5 from Q3 2024. 5 opened new positions and 1 sold out. The largest holders were Morgan Stanley ($73K), Susquehanna International Group, LLP ($26K) and Geode Capital Management, LLC ($19K).
Company
TNF Pharmaceuticals Inc.
CUSIP
62856X201
Latest filing quarter
Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
Institutions
Total Value
New Positions
5
$26K
Exits
1
$55
All 13F filers, Q3 2024 → Q4 2024: 89,700 shares bought and 72 shares sold, net +89,628 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.